Literature DB >> 2413707

Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study.

M Zech, B Bogerts.   

Abstract

The distribution of methionine-enkephalin (ME)-like and substance P (SP)-like immunoreactivity in the basal ganglia of untreated schizophrenics as compared with normal control cases, and untreated Huntington and Parkinson patients was studied using the unlabeled peroxidase-antiperoxidase (PAP) method. ME but not SP was reduced in the pallidum of one of six schizophrenics. The remaining five cases showed no differences to the controls. In contrast, no or only very faint homogeneously distributed ME and SP was found in any part of the basal ganglia in Huntington's disease. In Parkinson's disease, SP immunoreactivity was within normal range.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413707     DOI: 10.1007/bf00688953

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  42 in total

1.  Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals.

Authors:  A Ljungdahl; T Hökfelt; G Nilsson
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

2.  Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.

Authors:  S H Buck; T F Burks; M R Brown; H I Yamamura
Journal:  Brain Res       Date:  1981-03-30       Impact factor: 3.252

3.  Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain.

Authors:  I Kanazawa; P C Emson; A C Cuello
Journal:  Brain Res       Date:  1977-01-07       Impact factor: 3.252

4.  Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.

Authors:  A Mauborgne; F Javoy-Agid; J C Legrand; Y Agid; F Cesselin
Journal:  Brain Res       Date:  1983-05-23       Impact factor: 3.252

5.  Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry.

Authors:  S N Haber; W J Nauta
Journal:  Neuroscience       Date:  1983-06       Impact factor: 3.590

6.  Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.

Authors:  P E Marshall; D M Landis; E L Zalneraitis
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

7.  The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system.

Authors:  T Hökfelt; R Elde; O Johansson; L Terenius; L Stein
Journal:  Neurosci Lett       Date:  1977-06       Impact factor: 3.046

8.  [The morphology of substance P in the human brain as determined by an immuno-histo-fluorescence study].

Authors:  J Constantinidis; C Taban; R Guntern; R Tissot
Journal:  Schweiz Arch Neurol Neurochir Psychiatr       Date:  1980

9.  Neurotransmitters contained in the efferents of the striatum.

Authors:  W A Staines; J I Nagy; S R Vincent; H C Fibiger
Journal:  Brain Res       Date:  1980-08-04       Impact factor: 3.252

10.  Regional distribution of methionine-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary.

Authors:  C Gramsch; V Höllt; P Mehraein; A Pasi; A Herz
Journal:  Brain Res       Date:  1979-08-03       Impact factor: 3.252

View more
  4 in total

1.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

2.  Differential loss of striatal projection neurons in Huntington disease.

Authors:  A Reiner; R L Albin; K D Anderson; C J D'Amato; J B Penney; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study.

Authors:  M Zech; G W Roberts; B Bogerts; T J Crow; J M Polak
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 4.  Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.

Authors:  M O Trépanier; K E Hopperton; R Mizrahi; N Mechawar; R P Bazinet
Journal:  Mol Psychiatry       Date:  2016-06-07       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.